T.J. Sharpe, a cancer survivor, understands the impact of clinical trials and the importance of educating others.
At age 37, in August 2012, Sharpe was diagnosed with stage IV melanoma. He was given two years to live and was advised to undergo the chemotherapy standard of care.
After receiving four second opinions, he enrolled in a clinical trial, which ended up failing. However, after two more clinical trials, four immunotherapies and six surgeries, Sharpe is now responding well.
Today, because of clinical trials, Sharpe has gotten progressively better. After vowing to make a difference in the lives of other patients, he regularly shares his experiences with clinical trials through his blog and speaking engagements.